Regina Brown

All filings by Regina Brown on record concern Lixte Biotechnology Holdings, Inc. We count 2 filings, every one of them for a trade on 21 November 2022.

Every open-market trade on record is a purchase: 2 purchases worth €2,784, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

Most recently, on 22 November 2022, the filings show an open-market purchase worth €1,460 in Lixte Biotechnology Holdings, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.